Research shows that when we speak about “making time" and not about “having time," we feel more in control and more motivated ...
Between 2008 and 2010, polarization in society increased dramatically alongside a significant shift in social behavior: the ...
Most successful fertility treatments for women 43 and older rely on donor eggs, researchers reported in a new study published ...
Researchers said some users experience shame, disappointment, frustration and futility when using fitness apps, undermining ...
ScienceAlert on MSN
Study Reveals 2 Genes That Could Influence Your Interest in Cannabis
The genes we inherit may have a subtle influence over whether we experiment with and make a habit of using cannabis. A team ...
In this video, explore the invigorating Yoga Spinal Twist—an essential move for increasing flexibility and improving spinal health. Ideal for all levels, this session will guide you through techniques ...
Sanofi SA (NASDAQ:SNY) on Wednesday released topline data from a phase 2 study evaluating the efficacy and safety of AlphaMedix (212Pb-DOTAMTATE). The patients had unresectable or metastatic ...
AlphaMedix TM (212 Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors ...
Sanofi’s $110 million bet on a radioligand seems to be paying off after the neuroendocrine tumor treatment hit the key endpoints of a phase 2 study. The asset in question, dubbed AlphaMedix, is a ...
The mean dysmenorrhea pain score was reduced by 42% The mean non-menstrual pelvic pain score was reduced by 52% SHANGHAI, Oct. 7, 2025 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed'), a clinical-stage ...
Skye Bioscience’s obesity candidate has failed to reduce weight in a phase 2 study, marking another setback for the CB1 inhibitor class. The biotech had been evaluating a 200-mg weekly subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback